CLINICAL TRIALS PROFILE FOR RIDAURA
✉ Email this page to a colleague
All Clinical Trials for RIDAURA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01419691 ↗ | Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) | Completed | Kansas Bioscience Authority | Phase 2 | 2011-09-01 | The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL). |
NCT01419691 ↗ | Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) | Completed | The Leukemia and Lymphoma Society | Phase 2 | 2011-09-01 | The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL). |
NCT01419691 ↗ | Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) | Completed | Therapeutics for Rare and Neglected Diseases (TRND) | Phase 2 | 2011-09-01 | The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for RIDAURA
Condition Name
Clinical Trial Locations for RIDAURA
Trials by Country
Clinical Trial Progress for RIDAURA
Clinical Trial Phase
Clinical Trial Sponsors for RIDAURA
Sponsor Name